Citation:Luo M,Chen Y.Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.Int J Ophthalmol 2018;11(1):150-159,doi:10.18240/ijo.2018.01.23
Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future
Received:May 30, 2017  Revised:August 08, 2017
Email this Article  Add to Favorites  Print
DOI:10.18240/ijo.2018.01.23
Key Words:retinal pigmented epithelium transplantation; stem cell; human embryonic stem cell; induced pluripotent stem cell
Fund Project:
     
AuthorInstitution
Mingyue Luo Department of Ophthalmology, Peking Union Medical College Hospital, Beijing , China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing , China
Youxin Chen Department of Ophthalmology, Peking Union Medical College Hospital, Beijing , China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing , China
Hits: 889
Download times: 184
Abstract:
      As a constituent of blood-retinal barrier and retinal outer segment (ROS) scavenger, retinal pigmented epithelium (RPE) is fundamental to normal function of retina. Malfunctioning of RPE contributes to the onset and advance of retinal degenerative diseases. Up to date, RPE replacement therapy is the only possible method to completely reverse retinal degeneration. Transplantation of human RPE stem cell-derived RPE (hRPESC-RPE) has shown some good results in animal models. With promising results in terms of safety and visual improvement, human embryonic stem cell-derived RPE (hESC-RPE) can be expected in clinical settings in the near future. Despite twists and turns, induced pluripotent stem cell-derived RPE (iPSC-RPE) is now being intensely investigated to overcome genetic and epigenetic instability. By far, only one patient has received iPSC-RPE transplant, which is a hallmark of iPSC technology development. During follow-up, no major complications such as immunogenicity or tumorigenesis have been observed. Future trials should keep focusing on the safety of stem cell-derived RPE (SC-RPE) especially in long period, and better understanding of the nature of stem cell and the molecular events in the process to generate SC-RPE is necessary to the prosperity of SC-RPE clinical application.
PMC FullText Html:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767671/
Supplementary Material
PDF Fulltext  Download reader  HTML Fulltext   View/Add Comment